Platelets and vascular disease in gout.
D000493:Allopurinol / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000150:complications; D001792:Blood Platelets; D003078:Colchicine / Q000627:therapeutic use; D048909:Diabetes Complications; D006073:Gout / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D006218:Halofenate / Q000627:therapeutic use; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications; D006973:Hypertension / Q000150:complications; D007042:Hypoxanthines / Q000097:blood; D066298:In Vitro Techniques; D007674:Kidney Diseases / Q000150:complications; D014527:Uric Acid / Q000097:blood; D014528:Uricosuric Agents / Q000627:therapeutic use; D014652:Vascular Diseases / Q000150:complications*; D014970:Xanthines / Q000097:blood
D000700:Analgesics; D007042:Hypoxanthines; D014528:Uricosuric Agents; D014970:Xanthines; D014527:Uric Acid; D000493:Allopurinol; D006218:Halofenate; D003078:Colchicine